Olivier Féron

Active 1996–2025

Also published as
Olivier Feron
126
Papers
26,240
Citations
81
h-index
119
i10-index

Citations

Citations per year for Olivier Féron1990: 1 citations1991: 1 citations1996: 2 citations1997: 29 citations1998: 85 citations1999: 135 citations2000: 121 citations2001: 157 citations2002: 158 citations2003: 186 citations2004: 169 citations2005: 177 citations2006: 173 citations2007: 142 citations2008: 130 citations2009: 172 citations2010: 184 citations2011: 213 citations2012: 235 citations2013: 237 citations2014: 280 citations2015: 293 citations2016: 325 citations2017: 374 citations2018: 365 citations2019: 944 citations2020: 1,104 citations2021: 1,056 citations2022: 940 citations2023: 727 citations2024: 920 citations2025: 538 citations2026: 25 citations1992–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,700 citing papers, 22.9% of this breakdownChina: 2,008 citing papers, 17.1% of this breakdownUnited Kingdom: 622 citing papers, 5.3% of this breakdownGermany: 575 citing papers, 4.9% of this breakdownItaly: 556 citing papers, 4.7% of this breakdownBelgium: 461 citing papers, 3.9% of this breakdownFrance: 383 citing papers, 3.3% of this breakdownIndia: 365 citing papers, 3.1% of this breakdownCanada: 285 citing papers, 2.4% of this breakdownJapan: 270 citing papers, 2.3% of this breakdownSpain: 241 citing papers, 2% of this breakdownAustralia: 233 citing papers, 2% of this breakdown
0%22.9%Other 26.1%

Fields

  • Biochemistry, Genetics and Molecular Biology45.4%
  • Medicine30%
  • Materials Science8.2%
  • Engineering5.9%
  • Immunology and Microbiology4.2%
  • Neuroscience1.7%
  • Other4.6%

Topics

  • Cancer, Hypoxia, and Metabolism8.6%
  • Nanoparticle-Based Drug Delivery3.5%
  • Nanoplatforms for cancer theranostics3.4%
  • Nitric Oxide and Endothelin Effects2.8%
  • Mitochondrial Function and Pathology2.4%
  • Cancer, Lipids, and Metabolism2%
  • Other77.3%

Coauthors

All papers

Open in search
  1. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects

    Authors: , , , , , , , , , - Cell Metabolism 2021 cited by 494

  2. Tumour acidosis: from the passenger to the driver's seat

    Authors: , - Nature reviews. Cancer 2017 cited by 973

  3. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

    Authors: , , - Journal of Controlled Release 2010 cited by 2,748

  4. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2008 cited by 1,611

  5. Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis

    Authors: , , , , - Cancer Research 2011 cited by 793

  6. TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells

    Authors: , , , , , , , , , , , , , - Nature Communications 2020 cited by 321

  7. A roadmap for interpreting 13C metabolite labeling patterns from cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Wittmann, Matthew G. Vander Heiden, Alexei Vázquez, Karen H. Vousden, Jamey D. Young, Nicola Zamboni, Sarah‐Maria Fendt - Current Opinion in Biotechnology 2015 cited by 653

  8. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation

    Authors: , , , , , - Cell Metabolism 2016 cited by 336

  9. Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis

    Authors: , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 530

  10. A Mitochondrial Switch Promotes Tumor Metastasis

    Authors: , , , , , , , , , , , , , - Cell Reports 2014 cited by 599

  11. Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice

    Authors: , , , , , , - Angiogenesis 2012 cited by 248

  12. Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system

    Authors: , , , , - Journal of Controlled Release 2021 cited by 107

  13. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 188

  14. The SIRT1/HIF2α Axis Drives Reductive Glutamine Metabolism under Chronic Acidosis and Alters Tumor Response to Therapy

    Authors: , , , , , , - Cancer Research 2014 cited by 165

  15. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells

    Authors: - Radiotherapy and Oncology 2009 cited by 555

  16. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

    Authors: , , , , , , , , , , , , - British Journal of Cancer 2012 cited by 307

  17. Cycling hypoxia: A key feature of the tumor microenvironment

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016 cited by 243

  18. Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors

    Authors: , , , , , , , - Cancer Research 2011 cited by 219

  19. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy

    Authors: , , , - Frontiers in Immunology 2022 cited by 58

  20. Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids

    Authors: , , , , , , - Journal of the American Chemical Society 2019 cited by 118

  21. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments

    Authors: , - Disease Models & Mechanisms 2011 cited by 299

  22. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation

    Authors: , , , , , , - Journal of Controlled Release 2008 cited by 606

  23. Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force

    Authors: , - Journal of Internal Medicine 2013 cited by 230

  24. Effects of Vascular Endothelial Growth Factor on the Lymphocyte-Endothelium Interactions: Identification of Caveolin-1 and Nitric Oxide as Control Points of Endothelial Cell Anergy

    Authors: , , , , - The Journal of Immunology 2007 cited by 198